{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:34:25Z","timestamp":1792064065645,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11657-020-00853-x","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T22:02:25Z","timestamp":1605304945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bone mineral density among Palestinian patients suffering from hemoglobinopathy disorders"],"prefix":"10.1007","volume":"15","author":[{"given":"Akram","family":"Kharroubi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Karmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Shamasneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"853_CR1","unstructured":"Ahmad E, Shaheen M (2019) Prevalence of hypogonadism in thalassemia major patients in Gaza strip. Al-Azhar University of Gaza, pp 55-64"},{"key":"853_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2147\/IJWH.S141936","volume":"9","author":"H Al Sabbah","year":"2017","unstructured":"Al Sabbah H, Khan S, Hamadna A, Abu Ghazaleh L, Dudin A, Karmi BA (2017) Factors associated with continuing emergence of beta-thalassemia major despite prenatal testing: a cross-sectional survey. Int J Women's Health 9:673\u2013679","journal-title":"Int J Women's Health"},{"key":"853_CR3","doi-asserted-by":"publisher","first-page":"573298","DOI":"10.1155\/2012\/573298","volume":"2012","author":"I Aslan","year":"2012","unstructured":"Aslan I, Canatan D, Balta N, Kacar G, Dorak C, Ozsancak A, Oguz N, Cosan R (2012) Bone mineral density in thalassemia major patients from antalya, Turkey. Int J Endocrinol 2012:573298","journal-title":"Int J Endocrinol"},{"key":"853_CR4","first-page":"18","volume":"12","author":"H Ayyash","year":"2018","unstructured":"Ayyash H, Sirdah M (2018) Hematological and biochemical evaluation of beta-thalassemia major (betaTM) patients in Gaza Strip: a cross-sectional study. Int J Health Sci (Qassim) 12:18\u201324","journal-title":"Int J Health Sci (Qassim)"},{"key":"853_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bcmd.2013.09.008","volume":"52","author":"M Baldini","year":"2014","unstructured":"Baldini M, Forti S, Orsatti A, Marcon A, Ulivieri FM, Airaghi L, Zanaboni L, Cappellini MD (2014) Thalassemic osteopathy: a new marker of bone deposition. Blood Cells Mol Dis 52:91\u201394","journal-title":"Blood Cells Mol Dis"},{"key":"853_CR6","doi-asserted-by":"crossref","unstructured":"Balogh E, Paragh G, Jeney V (2018) Influence of iron on bone homeostasis. Pharmaceuticals (Basel) 11","DOI":"10.3390\/ph11040107"},{"key":"853_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/ehm.11.29","volume":"4","author":"C Borgna-Pignatti","year":"2011","unstructured":"Borgna-Pignatti C, Gamberini MR (2011) Complications of thalassemia major and their treatment. Expert Rev Hematol 4:353\u2013366","journal-title":"Expert Rev Hematol"},{"key":"853_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","volume":"12","author":"A Cao","year":"2010","unstructured":"Cao A, Galanello R (2010) Beta-thalassemia. Genet Med 12:61\u201376","journal-title":"Genet Med"},{"key":"853_CR9","doi-asserted-by":"publisher","first-page":"e114972","DOI":"10.1371\/journal.pone.0114972","volume":"9","author":"SJ Chon","year":"2014","unstructured":"Chon SJ, Choi YR, Roh YH, Yun BH, Cho S, Choi YS, Lee BS, Seo SK (2014) Association between levels of serum ferritin and bone mineral density in Korean premenopausal and postmenopausal women: KNHANES 2008-2010. PLoS One 9:e114972","journal-title":"PLoS One"},{"key":"853_CR10","unstructured":"Daraghmeh N (2016) Management and complications of thalassemic patients in Palestine: retrospective study. An-Najah National University, pp 39-42"},{"key":"853_CR11","first-page":"119","volume":"29","author":"HM Darwish","year":"2005","unstructured":"Darwish HM, El-Khatib FF, Ayesh S (2005) Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine. Hemoglobin 29:119\u2013132","journal-title":"Hemoglobin"},{"key":"853_CR12","first-page":"167","volume":"11","author":"V De Sanctis","year":"2013","unstructured":"De Sanctis V, Soliman AT, Elsedfy H, Yassin M, Canatan D, Kilinc Y, Sobti P, Skordis N, Karimi M, Raiola G, Galati MC, Bedair E, Fiscina B, El Kholy M, I CET (2013) Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment. Pediatr Endocrinol Rev 11:167\u2013180","journal-title":"Pediatr Endocrinol Rev"},{"key":"853_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.metabol.2017.09.012","volume":"80","author":"V De Sanctis","year":"2018","unstructured":"De Sanctis V, Soliman AT, Elsefdy H, Soliman N, Bedair E, Fiscina B, Kattamis C (2018) Bone disease in beta thalassemia patients: past, present and future perspectives. Metabolism 80:66\u201379","journal-title":"Metabolism"},{"key":"853_CR14","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s00198-016-3719-z","volume":"27","author":"AD Dede","year":"2016","unstructured":"Dede AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, Dontas I, Papaioannou N, Tournis S (2016) Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease. Osteoporos Int 27:3409\u20133425","journal-title":"Osteoporos Int"},{"key":"853_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4274\/jcrpe.galenos.2018.2018.0074","volume":"11","author":"A Gaudio","year":"2019","unstructured":"Gaudio A, Morabito N, Catalano A, Rapisarda R, Xourafa A, Lasco A (2019) Pathogenesis of thalassemia major-associated osteoporosis: a review with insights from clinical experience. J Clin Res Pediatr Endocrinol 11:110\u2013117","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"853_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/nyas.13041","volume":"1368","author":"A Giusti","year":"2016","unstructured":"Giusti A, Pinto V, Forni GL, Pilotto A (2016) Management of beta-thalassemia-associated osteoporosis. Ann N Y Acad Sci 1368:73\u201381","journal-title":"Ann N Y Acad Sci"},{"key":"853_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1172-5-13","volume":"5","author":"CL Harteveld","year":"2010","unstructured":"Harteveld CL, Higgs DR (2010) \u03b1-thalassaemia. Orphanet J Rare Dis 5:13\u201321","journal-title":"Orphanet J Rare Dis"},{"key":"853_CR18","first-page":"143","volume":"6","author":"M Hashemieh","year":"2014","unstructured":"Hashemieh M, Azarkeivan A, Radfar M, Saneifard H, Hosseini-Zijoud SM, Noghabaei G, Yaseri M (2014) Prevalence of osteoporosis among thalassemia patients from Zafar adult thalassemia clinic, Iran. IJBC 6:143\u2013148","journal-title":"IJBC"},{"key":"853_CR19","first-page":"EP307","volume":"49","author":"EM Iancu","year":"2017","unstructured":"Iancu EM, Albu AI, Nicolaescu I (2017) Risk factors associated with osteoporosis in beta-thalassaemia major patients. Endocr Abstr 49:EP307","journal-title":"Endocr Abstr"},{"key":"853_CR20","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1046\/j.1365-2141.1998.01108.x","volume":"103","author":"CE Jensen","year":"1998","unstructured":"Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV, Wonke B (1998) High prevalence of low bone mass in thalassaemia major. Br J Haematol 103:911\u2013915","journal-title":"Br J Haematol"},{"key":"853_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11657-017-0306-7","volume":"12","author":"A Kharroubi","year":"2017","unstructured":"Kharroubi A, Saba E, Smoom R, Bader K, Darwish H (2017) Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women. Arch Osteoporos 12:13","journal-title":"Arch Osteoporos"},{"key":"853_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5694\/j.1326-5377.2008.tb01525.x","volume":"188","author":"GL Kidson-Gerber","year":"2008","unstructured":"Kidson-Gerber GL, Francis S, Lindeman R (2008) Management and clinical outcomes of transfusion-dependent thalassaemia major in an Australian tertiary referral clinic. Med J Aust 188:72\u201375","journal-title":"Med J Aust"},{"key":"853_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.bjhh.2016.09.003","volume":"38","author":"D Langhi Jr","year":"2016","unstructured":"Langhi D Jr, Ubiali EM, Marques JF Jr, Verissimo MA, Loggetto SR, Silvinato A, Bernardo WM (2016) Guidelines on beta-thalassemia major - regular blood transfusion therapy: Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associacao Medica Brasileira - 2016. Rev Bras Hematol Hemoter 38:341\u2013345","journal-title":"Rev Bras Hematol Hemoter"},{"key":"853_CR24","doi-asserted-by":"crossref","unstructured":"Meena MC, Hemal A, Satija M, Arora SK, Bano S (2015) Comparison of bone mineral density in thalassemia major patients with healthy controls. Advances in Hematology 2015:648349","DOI":"10.1155\/2015\/648349"},{"key":"853_CR25","doi-asserted-by":"crossref","unstructured":"Nakhakesa C, Jaruluxanananb S, Saengsudac Y, Saengsudac S (2015) Risk factors for osteoporosis and the relationship between osteoporosis and hemoglobin level in adult patients with thalassemia in Rajavithi hospital. Asian Biomedicine 9:169\u2013174","DOI":"10.5372\/1905-7415.0902.383"},{"key":"853_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00774-003-0435-5","volume":"21","author":"P Pennisi","year":"2003","unstructured":"Pennisi P, Pizzarelli G, Spina M, Riccobene S, Fiore CE (2003) Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoporosis. J Bone Miner Metab 21:402\u2013408","journal-title":"J Bone Miner Metab"},{"key":"853_CR27","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1182\/blood-2018-99-113465","volume":"132","author":"P Piriyakhuntorn","year":"2018","unstructured":"Piriyakhuntorn P, Tantiworawit, Phimphilai M, Srichairatanakool S, Teeyasoontranon W, Rattanathammethee T, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, Charoenkwan P (2018) Prevalence and risk factors of low bone mineral density and fractures of young thalassemia patients. Blood 132:3636","journal-title":"Blood"},{"key":"853_CR28","first-page":"121","volume":"4","author":"KA Rafsanjani","year":"2009","unstructured":"Rafsanjani KA, Razzaghy-Azar M, Zahedi-Shoolami L, Vossough P, Modarres A, Taheri N (2009) Bone mineral density in \u03b2 thalassemia major and intermedia, correlation with biochemical and hormonal profiles. IJBC 4:121\u2013127","journal-title":"IJBC"},{"key":"853_CR29","doi-asserted-by":"publisher","first-page":"e2013057","DOI":"10.4084\/mjhid.2013.057","volume":"5","author":"A Soliman","year":"2013","unstructured":"Soliman A, De Sanctis V, Yassin M (2013) Vitamin D status in thalassemia major: an update. Mediterr J Hematol Infect Dis 5:e2013057","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"853_CR30","doi-asserted-by":"publisher","first-page":"537673","DOI":"10.4061\/2010\/537673","volume":"2010","author":"M Toumba","year":"2010","unstructured":"Toumba M, Skordis N (2010) Osteoporosis syndrome in thalassaemia major: an overview. J Osteoporos 2010:537673","journal-title":"J Osteoporos"},{"key":"853_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s42000-018-0019-3","volume":"17","author":"AN Tsartsalis","year":"2018","unstructured":"Tsartsalis AN, Lambrou GI, Tsartsalis D, Savvidis C, Karantza M, Terpos E, Kanaka-Gantenbein C, Chrousos GP, Kattamis A (2018) The role of biphosphonates in the management of thalassemia-induced osteoporosis: a systematic review and meta-analysis. Hormones (Athens) 17:153\u2013166","journal-title":"Hormones (Athens)"},{"key":"853_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2174\/1566524019666190314114447","volume":"19","author":"AN Tsartsalis","year":"2019","unstructured":"Tsartsalis AN, Lambrou GI, Tsartsalis DN, Papassotiriou I, Vlachou E, Terpos E, Chrousos GP, Kanaka-Gantenbein C, Kattamis A (2019) Bone metabolism markers in thalassemia major-induced osteoporosis: results from a cross-sectional observational study. Curr Mol Med 19:335\u2013341","journal-title":"Curr Mol Med"},{"key":"853_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/03630269.2014.905792","volume":"38","author":"P Tzoulis","year":"2014","unstructured":"Tzoulis P, Ang AL, Shah FT, Berovic M, Prescott E, Jones R, Barnard M (2014) Prevalence of low bone mass and vitamin D deficiency in beta-thalassemia major. Hemoglobin 38:173\u2013178","journal-title":"Hemoglobin"},{"issue":"Suppl 1","key":"853_CR34","first-page":"86","volume":"6","author":"E Voskaridou","year":"2008","unstructured":"Voskaridou E, Terpos E (2008) Pathogenesis and management of osteoporosis in thalassemia. Pediatr Endocrinol Rev 6(Suppl 1):86\u201393","journal-title":"Pediatr Endocrinol Rev"},{"key":"853_CR35","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1002\/jbmr.2266","volume":"29","author":"P Wong","year":"2014","unstructured":"Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Kerr PG, Doery JC, Paul E, Bowden DK, Strauss BJ, Milat F (2014) Thalassemia bone disease: a 19-year longitudinal analysis. J Bone Miner Res 29:2468\u20132473","journal-title":"J Bone Miner Res"},{"key":"853_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1210\/er.2015-1105","volume":"37","author":"P Wong","year":"2016","unstructured":"Wong P, Fuller PJ, Gillespie MT, Milat F (2016) Bone disease in thalassemia: a molecular and clinical overview. Endocr Rev 37:320\u2013346","journal-title":"Endocr Rev"},{"key":"853_CR37","doi-asserted-by":"publisher","unstructured":"Yang WP, Chang HH, Li HY, Lai YC, Huang TY, Tsai KS, Lin KH, Lin DT, Jou ST, Lu MY, Yang YL, Chou SW, Shih SR. Iron Overload Associated Endocrine Dysfunction Leading to Lower Bone Mineral Density in Thalassemia Major. J Clin Endocrinol Metab. 2020 Apr 1;105(4):dgz309. https:\/\/doi.org\/10.1210\/clinem\/dgz309.PMID:31907538.","DOI":"10.1210\/clinem\/dgz309.PMID:31907538."},{"key":"853_CR38","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/08880010500278707","volume":"22","author":"M Yildiz","year":"2005","unstructured":"Yildiz M, Canatan D (2005) Soft tissue density variations in thalassemia major: a possible pitfall in lumbar bone mineral density measurements by dual-energy X-ray absorptiometry. Pediatr Hematol Oncol 22:723\u2013726","journal-title":"Pediatr Hematol Oncol"},{"key":"853_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/CCRR.1000373","volume":"3","author":"MMH Zadeh","year":"2017","unstructured":"Zadeh MMH, Hussain HY, Al Faisal W, Muhasin M (2017) Osteoporosis and associated factors among thalassemia patients referred to bone mineral density screening -Dubai Hospital, 2014-2017. Clin Case Rep Rev 3:1\u20134","journal-title":"Clin Case Rep Rev"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-020-00853-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11657-020-00853-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-020-00853-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T06:15:08Z","timestamp":1618380908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11657-020-00853-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["853"],"URL":"https:\/\/doi.org\/10.1007\/s11657-020-00853-x","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"181"}}